For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Arbor Biotechnologies, Inc.

USPTO Granted Patents = 26

EPO Patents = 2

Trademarks = 1

Forward Citations = 35

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

David Arthur Scott (21 out of 33 patents)

David R Cheng (20 out of 21 patents)

Winston X Yan (20 out of 29 patents)

4. Shaorong Chong (10 out of 14 patents)

5. Pratyusha Hunnewell (6 out of 6 patents)

6. Quinton Norman Wessells (5 out of 5 patents)

7. Tia M DiTommaso (4 out of 4 patents)

8. Noah Michael Jakimo (4 out of 4 patents)

9. Tia Marie Ditommaso (4 out of 4 patents)

10. Brendan Jay Hilbert (3 out of 3 patents)

11. Anthony James Garrity (3 out of 3 patents)

12. Sejuti Sengupta (2 out of 2 patents)

13. Jeffrey Raymond Haswell (2 out of 2 patents)

14. Wei-Cheng Lu (2 out of 2 patents)

15. Lauren E Alfonse (2 out of 2 patents)

Core Competencies:

CRISPR

Gene Editing

Nuclease

Polypeptide

RNA Guide

Transposon Systems

Targeting Enzymes

Compositions

Cas12i

Variants

Hydroxyacid Oxidase

Lactate Dehydrogenase

26 patents: Sort by Forward Citations

1. 12747457 - COMPOSITIONS COMPRISING A CAS12I POLYPEPTIDE AND USES THEREOF (2026-09-29),

2. 12716060 - NOVEL CRISPR-ASSOCIATED SYSTEMS AND COMPONENTS (2026-08-25),

3. 12655421 - NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS (2026-06-16),

4. 12655404 - NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS (2026-06-16),

5. 12553045 - Crispr DNA targeting enzymes and systems (2026-02-17),

6. 12522812 - NOVEL CRISPR-ASSOCIATED SYSTEMS AND COMPONENTS (2026-01-13),

7. 12460203 - CRISPR RNA targeting enzymes and systems and uses thereof (2025-11-04),

8. 12460190 - CRISPR DNA targeting enzymes and systems (2025-11-04),

9. 12344870 - Compositions comprising a CRISPR nuclease and uses thereof (2025-07-01),

10. 12195770 - CRISPR DNA and RNA targeting enzymes and systems (2025-01-14),

11. 12054754 - CRISPR-associated transposon systems and components (2024-08-06),

12. 11976308 - CRISPR DNA targeting enzymes and systems (2024-05-07),

13. 11946045 - Compositions comprising a variant polypeptide and uses thereof (2024-04-02),

14. 11939607 - Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereof (2024-03-26),

15. 11912992 - CRISPR DNA targeting enzymes and systems (2024-02-27),

Arbor Biotechnologies, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative gene editing technologies. The organization focuses on harnessing the power of CRISPR and other advanced molecular tools to enable precise modifications in genetic material. Arbor's research aims to address challenges in various fields, including agriculture, healthcare, and environmental sustainability, by providing solutions that enhance genetic engineering capabilities and promote scientific advancements.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Arbor Biotechnologies, Inc.

26 Patents

#103 in Cambridge, MA

#774 in Massachusetts

#12,843 in US

#24,758 in the World

Cambridge, MA, United States of America

Arbor Biotechnologies, Inc.

Forward Citations = 35

18 inventors:

David Arthur Scott (21 out of 33 patents)

David R Cheng (20 out of 21 patents)

Winston X Yan (20 out of 29 patents)

4. Shaorong Chong (10 out of 14 patents)

5. Pratyusha Hunnewell (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…